每年一度的医保谈判始终是业界翘首以待的盛事。自2018年国家医保局正式成立以来,国家医保局通过将创新药物以公允的价格及时纳入医保目录,以及支持其临床应用的加速等措施,极大地推动了创新药物的发展进程。 11月28日,国家医保局详细介绍了2024年国家医保药品目录的调整情况,并正式对外发布了《国家基本医疗保险、工伤保险和生育保险药品目录(2024年版)》。此次调整新增了91种药品,包括针对肺癌、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.